The cardiovascular risk of tiotropium: is it real? (Q37766601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

6 February 2020

review article

1 reference

title

The cardiovascular risk of tiotropium: is it real? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Mario Cazzola

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

6 February 2020

Maria Gabriella Matera

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

6 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

6 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

783-792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20565229 AND SRC:MED&resulttype=core&format=json

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

From large clinical trials to management of COPD in the real world

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Hospitalizations and mortality in the Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Ipratropium and lung health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Cardiovascular events associated with ipratropium bromide in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Acetylcholine release in human heart atrium: influence of muscarinic autoreceptors, diabetes, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Muscarinic receptors in the mammalian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Pilocarpine modulates the cellular electrical properties of mammalian hearts by activating a cardiac M3 receptor and a K current

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Function of cardiac M3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Differential alterations of receptor densities of three muscarinic acetylcholine receptor subtypes and current densities of the corresponding K channels in canine atria with atrial fibrillation induced by experimental congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Effects of atropine on human cardiac beta 1- and/or beta 2-adrenoceptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Inhaled tiotropium bromide and risk of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Cardiovascular safety of tiotropium in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Tiotropium bromide: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Effects of atropine and pirenzepine on heart rate turbulence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Effect of atropine on heart rate turbulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611

Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14740338.2010.500611